{
 "url": "https://etfiq.com/funds/ozem/holdings/",
 "section": "funds",
 "title": "OZEM Holdings: All 24 Positions (Oct 14, 2026) | ETFIQ",
 "description": "All 24 OZEM holdings with weights, as of Oct 14, 2026. The top 3 are LLY 14.21%, NVO 11.96% and PFE 8.44%. Download the full list as a CSV.",
 "as_of": "Oct 14, 2026",
 "ticker": "OZEM",
 "fund": "Roundhill GLP-1 & Weight Loss ETF",
 "fund_page": "https://etfiq.com/funds/ozem",
 "positions": 24,
 "positions_listed_on_page": 24,
 "lead": "OZEM held 24 positions as of Oct 14, 2026. Eli Lilly & Co is the largest at 14.21%; the top 10 are 67.9% of the fund.",
 "source": {
  "name": "Roundhill",
  "url": "https://www.roundhillinvestments.com/assets/data/filepointroundhill.40ru.ru_holdings_10142026.csv",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-14",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 14.21,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 2,
   "holding": "Novo Nordisk A/S",
   "ticker": "NVO",
   "weight_pct": 11.96,
   "page": null
  },
  {
   "rank": 3,
   "holding": "Pfizer Inc",
   "ticker": "PFE",
   "weight_pct": 8.44,
   "page": "https://etfiq.com/holdings/pfe/"
  },
  {
   "rank": 4,
   "holding": "CSPC Pharmaceutical Group Ltd",
   "ticker": null,
   "weight_pct": 6.11,
   "page": null
  },
  {
   "rank": 5,
   "holding": "Kailera Therapeutics Inc",
   "ticker": "KLRA",
   "weight_pct": 5.21,
   "page": null
  },
  {
   "rank": 6,
   "holding": "Chugai Pharmaceutical Co Ltd",
   "ticker": null,
   "weight_pct": 4.77,
   "page": "https://etfiq.com/holdings/4519/"
  },
  {
   "rank": 7,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 4.73,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 8,
   "holding": "Viking Therapeutics Inc",
   "ticker": "VKTX",
   "weight_pct": 4.58,
   "page": "https://etfiq.com/holdings/vktx/"
  },
  {
   "rank": 9,
   "holding": "AstraZeneca PLC",
   "ticker": "AZN",
   "weight_pct": 4.07,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 10,
   "holding": "Hanmi Pharm Co Ltd",
   "ticker": null,
   "weight_pct": 3.8,
   "page": null
  },
  {
   "rank": 11,
   "holding": "Roche Holding AG",
   "ticker": null,
   "weight_pct": 3.52,
   "page": null
  },
  {
   "rank": 12,
   "holding": "Zealand Pharma A/S",
   "ticker": null,
   "weight_pct": 3.47,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Ascletis Pharma Inc",
   "ticker": null,
   "weight_pct": 3.31,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Jiangsu Hengrui Pharmaceuticals Co Ltd",
   "ticker": null,
   "weight_pct": 2.88,
   "page": null
  },
  {
   "rank": 15,
   "holding": "United Laboratories International Holdings Ltd/The",
   "ticker": null,
   "weight_pct": 2.85,
   "page": null
  },
  {
   "rank": 16,
   "holding": "Hansoh Pharmaceutical Group Co Ltd",
   "ticker": null,
   "weight_pct": 2.64,
   "page": "https://etfiq.com/holdings/hansoh-pharmaceutical-group/"
  },
  {
   "rank": 17,
   "holding": "Innovent Biologics Inc",
   "ticker": null,
   "weight_pct": 2.38,
   "page": "https://etfiq.com/holdings/innovent-biologics/"
  },
  {
   "rank": 18,
   "holding": "Gubra A/S",
   "ticker": null,
   "weight_pct": 2.2,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 2.03,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 20,
   "holding": "MBX Biosciences Inc",
   "ticker": "MBX",
   "weight_pct": 1.86,
   "page": "https://etfiq.com/holdings/mbx/"
  },
  {
   "rank": 21,
   "holding": "Structure Therapeutics Inc",
   "ticker": "GPCR",
   "weight_pct": 1.85,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Rhythm Pharmaceuticals Inc",
   "ticker": "RYTM",
   "weight_pct": 1.43,
   "page": "https://etfiq.com/holdings/rytm/"
  },
  {
   "rank": 23,
   "holding": "Shionogi & Co Ltd",
   "ticker": null,
   "weight_pct": 1.36,
   "page": "https://etfiq.com/holdings/4507/"
  },
  {
   "rank": 24,
   "holding": "Wave Life Sciences Inc",
   "ticker": "WVE",
   "weight_pct": 0.26,
   "page": null
  }
 ],
 "top_positions_shown": 24,
 "cash": [
  {
   "holding": "First American Government Obligations Fund 12/01/2031",
   "weight_pct": 0.35
  },
  {
   "holding": "Swiss Franc",
   "weight_pct": -0.48
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.21
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/ozem/holdings/ozem-holdings.csv",
 "json_book": "https://etfiq.com/data/books/ozem.json",
 "markdown": "https://etfiq.com/funds/ozem/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of OZEM, data as of Oct 14, 2026. https://etfiq.com/funds/ozem/holdings/"
}